0001709440-20-000003.txt : 20200124 0001709440-20-000003.hdr.sgml : 20200124 20200124152236 ACCESSION NUMBER: 0001709440-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200124 DATE AS OF CHANGE: 20200124 EFFECTIVENESS DATE: 20200124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Plakous Therapeutics, Inc. CENTRAL INDEX KEY: 0001709440 IRS NUMBER: 812037804 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358913 FILM NUMBER: 20545187 BUSINESS ADDRESS: STREET 1: 755 HIGHLAND OAKS DRIVE STREET 2: SUITE 103 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 BUSINESS PHONE: 336-782-3106 MAIL ADDRESS: STREET 1: 755 HIGHLAND OAKS DRIVE STREET 2: SUITE 103 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 D 1 primary_doc.xml X0708 D LIVE 0001709440 Plakous Therapeutics, Inc. 755 HIGHLAND OAKS DRIVE SUITE 103 WINSTON-SALEM NC NORTH CAROLINA 27103 336-782-3106 NORTH CAROLINA None None Corporation true 2016 Scott A. Washburn 755 Highland Oaks Drive Suite 103 Winston-Salem NC NORTH CAROLINA 27103 Executive Officer Director President Seth Tomblyn 755 Highland Oaks Drive Suite 103 Winston-Salem NC NORTH CAROLINA 27103 Executive Officer Director Secretary and Treasurer Peter Johnson 755 Highland Oaks Drive Suite 103 Winston-Salem NC NORTH CAROLINA 27103 Director Allison London Brown 755 Highland Oaks Drive Suite 103 Winston-Salem NC NORTH CAROLINA 27103 Director Robert W. Boyce 755 Highland Oaks Drive Suite 103 Winston-Salem NC NORTH CAROLINA 27103 Executive Officer CEO Biotechnology Decline to Disclose 06b false 2019-03-08 true true Convertible promissory notes false 25000 4000000 175000 3825000 false 3 0 0 0 true The proceeds will be used for working capital, which the issuer anticipates may include compensation (estimated to be approximately 12.5% of total proceeds) to named executive officers. false Plakous Therapeutics, Inc. /s/ Scott A. Washburn Scott A. Washburn President 2020-01-24